ArticleTranslational andrology and urology2025

Metastatic renal cell carcinoma disease response in the era of immune checkpoint inhibitor-based combinations.

Micah Ostrowski et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.